Pune, June 20, 2019 (GLOBE NEWSWIRE) -- The rising prevalence of end stage renal disease and surge in demand for home dialysis treatment are anticipated to drive the global Peritoneal Dialysis Market, finds Fortune Business Insights in a new study. The study is titled “Peritoneal Dialysis Market: Global Market Analysis, Insights, and Forecasts, 2018 – 2025.” According to the study, the global Peritoneal Dialysis Market will rise at 6.9% CAGR and reach a value of US$ 6,077.2 Mn by 2025 from US$ 3,589.9 Mn.
The automated peritoneal dialysis (APD) segment emerged as the most attractive therapy type in the past. It is one of the preferred types of renal replacement treatment among people suffering from end-stage renal diseases. In 2015, National Center for Biotechnology Information (NCBI) published an article, which stated that about 60% of the patients in the U.S., diagnosed with peritoneal dialysis prefer APD rather than other treatment methods, while the number of people opting for APD in Europe is 50%. This is because of the recent advancements in the technology, increasing popularity of the cycler, and new product developments that APD is further expected to continue its dominance during the forecast period.
Sample PDF https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/peritoneal-dialysis-market-100089
Rising Preference for Dialysis Treatment at Home to Drive Market
The global Peritoneal Dialysis Market is witnessing growth due to several reasons. One of the major factors propelling demand for the market is the increasing geriatric population and their vulnerability towards chronic disorders such as hypertension, diabetes, and kidney disorders. Besides recent advancements in technology, patients are likely to opt for peritoneal dialysis due to the rise in their disposable income and increasing willingness to spend on advanced treatments. The above factors all help the Peritoneal Dialysis Market exhibit a steady growth in the future.
Other factors driving the global Peritoneal Dialysis Market are the increasing prevalence of end stage renal disease (ESRD), and the increasing demand for dialysis treatment at home setup. Moreover, peritoneal dialysis offers advantages such as needle free treatment, portability, few dietary restrictions, and lower treatment cost as compared to hemodialysis, that are further increasing its potentiality for better results in the future. Thus, the market for peritoneal dialysis is likely to witness progressive growth rates owing to factors mentioned above in the near future.
On the flipside, there are certain risks associated with peritoneal dialysis such as risk of infection, hernia, weight gain, peritonitis, and others. These concerns may cause hinder the growth of the market to an extent.
Asia Pacific to Emerge Dominant on Account of Better Growth Opportunities from Developed Nations
The number of people affected by renal problems is increasing by the day, especially in under developed or developing areas with limited access to healthcare facilities. The launch of awareness programs by governments of such nations are helping the market for peritoneal dialysis to gain more traction. The market in Asia Pacific is expected to rise at a faster rate due to the advent of new technology, and increasing number of healthcare and medical centers in the region. In 2017, Asia Pacific generated a revenue of US$ 1,194.1 Mn owing to the rising adoption of peritoneal dialysis in the developing nations of China and India. Government support and adequate reimbursement policies will help the market in the region to emerge dominant during the forecast period.
Speak to Analyst: https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/peritoneal-dialysis-market-100089
Major players are investing huge sums into research and development programs for the discovery of better therapeutic options. New product launches, mergers and acquisitions, and other strategies adopted by market players will help the market to generate more revenues in the near future.
Key Companies Mentioned in Report
- Baxter International Inc.
- Fresenius Kabi AG
- Medtronic
- Utah Medical Products, Inc.
- Glomeria Therapeutics
- Poly Medicure Ltd.
- Cook Medical Inc.
- CardioMed Supplies Inc.
- Medical Components, Inc.
- Other players
Browse Complete Report Details Enabled with Complete Tables and Figures:
https://www.fortunebusinessinsights.com/industry-reports/peritoneal-dialysis-market-100089
Major Table of Content:
- Market Dynamics
- Market Drivers
- Market Restraints
- Market Opportunities & Trends
- Key Insights
- Global Prevalence of CKD (2016)
- Global Prevalence of treated End-stage Renal Disease (2016)
- Estimated Number of Patients on HD vs PD (2017)
- Overview of Major Dialysis Services Providers
- Number of Nephrologists (2016)
- Number of Nephrologists by Continent (2016)
- Global Peritoneal Dialysis (PD) Market Analysis, Insights and Forecast, 2014-2025
- Key Findings / Summary
- Market Analysis, Insights and Forecast – By Type
- CAPD
- APD
- Market Analysis, Insights and Forecast – By Product
- Cyclers
- Fluids
- Others Accessories
- Market Analysis, Insights and Forecast – By End User
- Home Health Care
- Hospital & Others
- Market Analysis, Insights and Forecast – By Geography
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
- Key Findings / Summary
- Competitive Landscape
- Strategic Recommendations
Request for Customization: https://www.fortunebusinessinsights.com/enquiry/customization/peritoneal-dialysis-market-100089
Browse Related Reports:
- Orphan Drugs Market Size, Share and Global Trend by Therapy Area (Oncology, Blood, CNS, Endocrine, Cardiovascular, Respiratory, Immunomodulatory), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Sales) and Geography Forecast till 2025
- Dialyzers Market Size, Share and Global Trend by Flux Type (High-flux, Low-Flux), By Usage Type (Disposable, Reusable), By End User (Dialysis Centers and Hospitals, Home Healthcare), and Geography Forecast till 2026
- Diabetes Drugs Market Size, Share and Global Trend by Drug Class (Insulin, DPP-4 Inhibitors, GLP-1 Receptor Agonists, SGLT2 Inhibitors), Diabetes Type (Type 1, Type 2), Route of Administration (Oral, Subcutaneous, Intravenous), Distribution Channel (Online pharmacies, Hospital Pharmacies, Retail Pharmacies) & Geography Forecast till 2026
About us:
Fortune Business Insights offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.
Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.
At Fortune Business Insights we aim at highlighting the most lucrative growth opportunities for our clients. We therefore offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.
Contact us:
Fortune Business Insights Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune-Bangalore Highway,
Pune - 411045, Maharashtra, India.
US :+1-424-253-0390
UK :+44-2071-939123
APAC :+91-744-740-1245
Email: sales@fortunebusinessinsights.com
Website: https://www.fortunebusinessinsights.com
Attachment